Cargando…
The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
BACKGROUND: Lipocalin-2 (LCN2) has a critical effect on obesity as well as its associated comorbidities. The present study focused on analyzing serum LCN2 levels of obese patients with nonalcoholic fatty liver disease (NAFLD) and on determining relationship of hepatic steatosis improvement with LCN2...
Autores principales: | Chen, Jiaqi, Lei, Shihui, Huang, Yueye, Zha, Xiaojuan, Gu, Lei, Zhou, Donglei, Li, Jun, Liu, Feng, Li, Nannan, Du, Lei, Huang, Xiu, Lin, Ziwei, Bu, Le, Qu, Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761269/ https://www.ncbi.nlm.nih.gov/pubmed/35034646 http://dx.doi.org/10.1186/s12944-022-01622-0 |
Ejemplares similares
-
Correction: The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2023) -
Development of a New Index Based on Preoperative Serum Lipocalin 2 to Predict Post-LSG Weight Reduction
por: Li, Nannan, et al.
Publicado: (2022) -
Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress
por: Wen, Xin, et al.
Publicado: (2021) -
Correction to: Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress
por: Wen, Xin, et al.
Publicado: (2023) -
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)